ストレプトコッカス肺炎菌による細菌血症. 治療と予防への影響. フランクリン郡肺炎研究グループ
J F Plouffe1, R F Breiman, R R Facklam
1Department of Internal Medicine, Ohio State University Medical Center, Columbus 43210, USA.
JAMA
|January 17, 1996
まとめ
Streptococcus pneumoniae bacteremiaは,高齢者やアフリカ系アメリカ人においてより一般的であり,抗菌剤耐性が増加しています. 肺炎球菌ワクチン接種と耐性パターンの認識は,効果的な治療に不可欠です.
科学分野:
- 感染症 感染症は感染症です.
- エピデミオロジー エピデミオロジー
- 微生物学 微生物学とは
背景:
- Streptococcus pneumoniaeは,細菌性感染症の主要な原因である.
- S. pneumoniaeの疫学と抗菌剤耐性を理解することは,公衆衛生にとって極めて重要です.
研究 の 目的:
- ストレプトコッカス肺炎菌血症の発生率と死亡率を決定する.
- 流行する血清型とその抗菌剤感受性のパターンを特定する.
主な方法:
- 1991年から1994年にかけてのS.pneumoniaeの血液単離の将来的な症例確認.
- 人口統計データと499個の単離体に対する抗菌感受性試験のグラフレビュー.
主要な成果:
- 65歳以上 (83.0/100,000) の成人およびアフリカ系アメリカ人におけるより高い発生率.
- HIV感染者のリスクは41.8倍に増加した.
- 全体的な死亡率は19%で,年齢とともに増加し,1994年までに薬剤耐性菌株は24%に上昇した.
結論:
- 肺炎球菌ワクチンの使用の増加と耐性に対する認識が不可欠です.
- 医療従事者や患者に対して,抗菌剤の賢明な使用に関する教育プログラムが推奨されています.
さらに関連する動画
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
08:25Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
Published on: April 7, 2015
関連する概念動画
Pneumonia I: Introduction
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
